Graduate School in Molecular Pharmacology and Experimental Therapeutics

Mayo Clinic’s Molecular Pharmacology and Experimental Therapeutics Program (MPET) in the Mayo Graduate School has sent the following information to the chemistry department.

Are you seeking Ph.D. training for a career that melds the unparalleled thrill of discovering basic biological mechanisms with the excitement of translating those findings into the novel therapies for human diseases?  The Mayo Graduate School attracts outstanding students from across the world for a variety of reasons:

Exceptional Student Outcomes

Examples of our student’s successes include -

• Tremendous productivity during student training—Ph.D. (and M.D./Ph.D.) students graduating in the last 20 years averaged 5.6 publications, with publications in some of the very best journals in the world (e.g., Molecular Cell, Nature Immunology, Nature Genetics, Nature Cell Biology, PNAS, Neuron, Journal of Cell Biology, Journal of Biological Chemistry, Genes & Development, Nature Biotechnology).

• More than 90% of students go on to academic postdoctoral training at top-notch institutions.

• Former students now have careers as leaders in academia and industry.

• Funding of a highly competitive, peer-reviewed NIH pre-doctoral pharmacology training grant (T32GM072474)

• Students complete Ph.D. training in an average of 5.2 years.

Committed Mentors

Our faculty members are committed to fostering the intellectual development of students into future leaders in biomedical science (as demonstrated by our student outcomes!).  Our world-class investigators and mentors receive a total annual research budget of over $500 million every year. Students receive exceptional and focused mentorship and benefit from our outstanding 1:1 student-to-faculty ratio.

Cutting-Edge Research

Our research program in pharmacology is firmly rooted in basic science research that integrates across the disciplines of biochemistry, molecular biology, genetics, physiology, structural biology, materials science, genomics, bioinformatics, proteomics, and systems pharmacology.  The goals of these programs are to discover the basic mechanisms of disease and to translate these findings into novel therapies. 

• Cancer Biology and Therapeutics – Discover the molecular underpinnings that drive cancers and new approaches to treat these diseases

• Regenerative Medicine – Harnessing bioengineered stem cells as an individualized in vitro platform to discover, diagnose, and ultimately treat mechanisms of degenerative diseases such as cardiomyopathy.

• Pharmacogenomics and Genetics – Employ cutting-edge genetic technologies to discover, at the molecular and genetic levels, why humans have vastly different responses to drugs

• Drug Discovery—Use supercomputers and chemistry to discover and develop mechanism-based drugs

• Neurobiology and Genetics of Addiction—Develop sophisticated genetic models and methods to understand and treat addictive behaviors

• Cardiovascular Biology and Therapeutics—Identify molecular mechanisms and genetic defects that contribute to heart disease and develop improved therapies

Full Student Financial Support

• Annual stipend of $26,750 per year
• Full tuition scholarships are given to all admitted students (valued at $24,000 per year)
• Tuition scholarship and stipend are guaranteed by Mayo Graduate School for 5 years

To Apply

Applications are due by December 1, 2013. (Be sure to indicate MPET as your first choice!)  http://www.mayo.edu/mgs/phd-admissions.html

To learn more about the MPET program and mentor’s research programs http://www.mayo.edu/mgs/mpet.html